Japan approves bill to offer all residents free COVID-19 vaccines
With a budget of ¥671.4 billion, deals have been struck with AstraZeneca PLC and Pfizer Inc. for 120 million doses from each. Negotiations with Moderna Inc. are ongoing.
Oxford COVID-19 vaccine prompts immune response in adults, AstraZeneca says
The COVID-19 vaccine being developed by the University of Oxford produces a similar immune response in both older and younger adults, and adverse responses were lower among older people, British drug maker AstraZeneca PLC said on Monday. A vaccine that works is seen as a ...
The COVID-19 shot was first give to frontline workers, but has now been rolled out to employees of state-owned companies.
Japanese drug firm Shionogi hit by cyberattack and data breach
Japanese pharmaceutical firm Shionogi & Co. said Thursday that its Taiwanese subsidiary was hit by a cyberattack earlier this month leading to a data breach, although no information regarding the novel coronavirus vaccine it is currently developing was leaked. According to the company, import licenses ...
Fujifilm works with Shanghai firm to get Avigan approved in China
Fujifilm Holdings Corp. said on Thursday it has partnered with Shanghai-based Carelink Pharmaceutical Co. to seek approval in China for Avigan to treat COVID-19 and influenza. Carelink will use Fujifilm's data on Avigan's treatment of novel coronavirus infections and influenza to seek imported drug approval ...
Vaccine storage issues could leave 3 billion people without access
Low income people around the world who were among the hardest hit by the COVID-19 pandemic are also likely to be the last to recover from it.
WHO coronavirus vaccine drive bedeviled by familiar question: Who pays if things go wrong?
Who foots the bill if people in poor countries fall sick with unexpected side-effects from coronavirus vaccines? It's not clear and that's a big problem in the battle to beat COVID-19. The World Health Organization has so far left the question of financial claims unresolved ...
WHO says remdesivir and three other drugs have no effect on COVID-19 patients
The World Health Organization has said that trial results show remdesivir and three other drugs administered to people infected with the novel coronavirus "have little or no effect" in terms of lowering the morality rate. "Interim results from the Solidarity Therapeutics Trial, coordinated by the ...
Fujifilm seeks approval for Avigan as COVID-19 treatment in Japan
The move comes after a late-stage study showed reduced recovery times for patients with nonsevere symptoms.
Two shots being developed by CNBG which are still in the final, third phase of testing have been authorized for emergency use in the country.
Johnson & Johnson's COVID-19 vaccine trial paused over unexplained illness
A late-stage study of Johnson & Johnson’s COVID-19 vaccine candidate has been paused while the company investigates whether a study participant’s "unexplained illness” is related to the shot. The company said in a statement Monday evening that illnesses, accidents and other so-called adverse events "are ...
Japan pledges $130 million for fair access to COVID-19 vaccines
The country has already extended more than $1.54 billion worth of aid to fight the global pandemic since February.
